Neuromuscular Disorders

Papers
(The H4-Index of Neuromuscular Disorders is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
WMS General Information57
ENMC Themed Workshop announcement50
WMS General Information42
Editorial Board38
ENMC Mid-Career Mentoring Programme36
366P Social Vulnerability in Duchenne Muscular Dystrophy: The Impact on Boys and Carrier Mothers34
156P Phosphorylated neurofilament heavy chain in cerebrospinal fluid and plasma in clinically silent and childhood-onset SMA individuals from Serbia32
624P A new double-trouble phenotype: fascioscapulohumeral muscular dystrophy and familial amyotrophic lateral sclerosis.31
355P A comprehensive education and training programme for healthcare professionals in care and research for Duchenne muscular dystrophy developed from DMD Care UK and the DMD Hub31
81P Minimal clinically important differences in dysferlinopathy from the 10-year, multicenter Jain Clinical Outcome Study30
326P Acute adverse events after Zoledronic acid infusion are uncommon in patients with Duchenne muscular dystrophy previously treated with oral bisphosphonates27
279P Exploring myogenic tremor in an animal model of MYBPC1-associated myopathy: a comprehensive study26
95P Development of a myotropic gene therapy towards a first treatment for LGMDR723
389P Natural history of bone health in Duchenne muscular dystrophy: A systematic review and implications for the design of a clinical trial22
WMS 2024 Full Programme22
365P Duchenne video assessment 2.0 scorecard performance: evaluation of inter-item and inter-scorecard relationships22
203P Towards a better analysis of SMN2 structures and variants by complete sequencing of the SMN locus in an international cohort of 564 SMA patients21
17O Schwann cell transduction and PMP22 target engagement in non-human primates supports translation of RNAi-based gene therapy for CMT1A21
10O The neonatal screening of SMA in Ukraine: the 18 months of experience21
46P Congenital myopathies and muscular dystrophies in the UK: a comprehensive next generation sequencing analysis of frequencies over an 8-year period (2016-2023)21
271P Exploring the effects of the epi-drug Remodelin on murine myoblasts differentiation21
0.18981504440308